Reversion Clock: Timed Cardiometabolic Surveillance Panel After Weight-Drug Cessation

A scheduled lab-and-vitals panel (HbA1c, fasting glucose, lipids, triglycerides, blood pressure) with fixed draws at 3, 6, 12, and 18 months after a patient stops a weight-management medication, flagging reversion toward pre-treatment values so clinicians can intervene before the drug's cardiometabolic benefits fully reverse.